Amlodipine and Olmesartan Medoxomil Tablets recall: CGMP Deviations
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ…
Why was Amlodipine and Olmesartan Medoxomil Tablets recalled?
cGMP deviations
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: BAD62101A, Exp 2/2024
- Product
- Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ…
- Recalling firm
- Macleods Pharma Usa Inc
- Quantity
- 3,672 bottles
- Distribution
- USA Nationwide
- Recall date
- March 9, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)